Evidence map›Paper›PMID 39773780›Full record

ArticleJournal of medical microbiology2025

Safety and efficacy of lamivudine/dolutegravir vs. bictegravir/emtricitabine/tenofovir alafenamide in antiretroviral-naive adults with HIV-1 infection in Shanghai, China: a single-centre retrospective study.

Junyang Yang, Lin Wang, Xiaoran Zhang, Li Liu, Yinzhong Shen, Tangkai Qi, Zhenyan Wang, Wei Song, Yang Tang, Shuibao Xu and 5 more

Abstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of medical microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Junyang YangDepartment of Infection and Immunology, Shanghai Public Health Clinical Center, Fudan University, Shanghai, PR China.
Lin WangDepartment of Nursing, Shanghai Public Health Clinical Center, Fudan University, Shanghai, PR China.
Xiaoran ZhangNo. 2 High School of East China Normal University, SongJiang, Shanghai, PR China.
Li LiuDepartment of Infection and Immunology, Shanghai Public Health Clinical Center, Fudan University, Shanghai, PR China.
Yinzhong ShenDepartment of Infection and Immunology, Shanghai Public Health Clinical Center, Fudan University, Shanghai, PR China.
Tangkai QiDepartment of Infection and Immunology, Shanghai Public Health Clinical Center, Fudan University, Shanghai, PR China.
Zhenyan WangDepartment of Infection and Immunology, Shanghai Public Health Clinical Center, Fudan University, Shanghai, PR China.
Wei SongDepartment of Infection and Immunology, Shanghai Public Health Clinical Center, Fudan University, Shanghai, PR China.
Yang TangDepartment of Infection and Immunology, Shanghai Public Health Clinical Center, Fudan University, Shanghai, PR China.
Shuibao XuDepartment of Infection and Immunology, Shanghai Public Health Clinical Center, Fudan University, Shanghai, PR China.
Jianjun SunDepartment of Infection and Immunology, Shanghai Public Health Clinical Center, Fudan University, Shanghai, PR China.
Youming ChenDepartment of Infection and Immunology, Shanghai Public Health Clinical Center, Fudan University, Shanghai, PR China.
Yihong ShenDepartment of Community, Shanyang Community Health Service Center, Shanghai, PR China.
Jun ChenDepartment of Infection and Immunology, Shanghai Public Health Clinical Center, Fudan University, Shanghai, PR China.
Renfang ZhangDepartment of Infection and Immunology, Shanghai Public Health Clinical Center, Fudan University, Shanghai, PR China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-HIV AgentsEmtricitabineHeterocyclic Compounds, 3-RingHIV-1HIV InfectionsLamivudineOxazinesPiperazinesPyridonesTenofovirAdenineAdultAlanineAmidesCD4 Lymphocyte CountChinaAdenineAlanineAmidesAnti-HIV AgentsbictegravirDolutegravirDrug CombinationsEmtricitabineemtricitabine tenofovir alafenamideHeterocyclic Compounds, 3-RingHeterocyclic Compounds, 4 or More RingsLamivudineOxazinesPiperazinesPyridonesTenofovirtenofovir alafenamideantiretroviral therapybictegravirdual therapyefficacyHIV-1safety

Identifiers

PMID39773780
PMCPMC12451750

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.